SD Biosensor COVID-19 Test Kits Receive FDA Emergency Use Authorization

TORRANCE, Calif. - April 28, 2020 - PRLog -- The FDA has approved the Emergency Use Authorization (EUA) for SD Biosensor's test kits for rapidly diagnosing SARS-CoV-2, the coronavirus that causes COVID-19.

Standard M nCoV Real-Time Detection Test Kits are utilized by laboratories that perform a reverse transcriptase polymerase chain reaction (RT-PCR) on the specimen, which has been collected by a swab through the nose or mouth. The kits feature a one tube reaction for identification and detection of COVID-19 and includes all the reagents required for RT-PCR.  The test is performed by laboratories that are CLIA-certified for high-complexity testing.

The SD Biosensor test kits are distributed in the United States by Onsite Wellness of Torrance, CA.

Sang Kim, CEO of Onsite Wellness, states, "There has been a severe shortage of molecular test kits in the US, hindering our nation's mitigation strategies. The access to these highly valued kits from South Korea should be a considerable aid to our nation's war against the pandemic, both clinically and epidemiologically."

http://www.OnSiteWellnessMedicalSupply.com